The Archives of General Psychiatry published a randomized, controlled trial hailing ketamine as a promising treatment for depression among patients with bipolar disorder. The new paper says that in most cases ketamine "resulted in a robust and rapid (within minutes) antidepressant response."
Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.
Add new comment